These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from May 15 through May 21, 2025. Source: VerityData
Original Filings
Middleby $(MIDD)$ Garden Investment Management disclosed a new position in the food-service-equipment maker of 3,139,834 shares. Garden Investment purchased 503,968 of those shares from May 9 through May 16, 2025, at per share prices ranging from $138.87 to $149.81. Following those purchases, Garden Investment owns 5.9% of Middleby's outstanding stock. Shares of Middleby have gained about 9.1% since the beginning of this year.
Rocket Cos. $(RKT)$ ValueAct Capital disclosed a new position in the financial-services company of 15,125,609 shares. ValueAct purchased 9,160,900 of those shares from March 27 through May 15, 2025, at per share prices ranging from $11.30 to $13.74. Following those purchases, ValueAct owns 9.9% of Rocket's outstanding stock. Shares of Rocket have gained roughly 12.8% since the beginning of this year.
Decreases in Holdings
Diebold Nixdorf (DBD) Hein Park Capital Management lowered its stake in the financial and retail technology company to 1,542,511 shares. Hein Park did so through the sale of 490,593 Diebold Nixdorf shares from March 3 through May 16, 2025, at per share prices ranging from $42 to $49.54. Following the latest sales, Hein Park continues to own 4.1% of Diebold Nixdorf's outstanding stock, placing Hein Park below the 5% threshold that would require it to report further sales. Shares of Diebold Nixdorf have gained roughly 12.4% since the start of this year.
NextDecade $(NEXT)$ Valinor Management reduced its stake in the liquid-natural-gas producer to 12,993,013 shares. Valinor did so through the sale of 1,074,544 NextDecade shares from March 18 through May 13, 2025, at per share prices ranging from $8.25 to $9.71. Following the latest sales, Valinor continues to own 4.98% of NextDecade's outstanding stock, placing Valinor below the 5% threshold that would require it to report further sales. Shares of NextDecade have lost about 12.8% of their value since the start of this year.
Gulfport Energy $(GPOR)$ Silver Point Capital lowered its stake in the natural-gas-weighted exploration-and-production company to 3,690,252 shares. Silver Point did so through the sale of 610,000 Gulfport shares on May 13, 2025, for $194.84 apiece, then offset those sales through the purchase of 76,986 shares for the same price that day. Following the latest activity, Silver Point continues to own 19% of Gulfport's outstanding stock. Shares of Gulfport have gained about 5% since the start of this year.
BridgeBio Pharma $(BBIO)$ KKR Genetic Disorder reduced its stake in the biotechnology company to 13,260,971 shares. KKR Genetic Disorder did so through the sale of six million BridgeBio shares through an open market block sale on May 12, 2025, at a price of $34.20 per share. Following the sale, KKR Genetic Disorder continues to own 7% of BridgeBio's outstanding stock. Shares of BridgeBio have gained roughly 16.5% since the start of this year.
Email: editors@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 23, 2025 15:22 ET (19:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.